The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

Clinical trial NCT05550415 · RECRUITING

Trial details

NCT number: NCT05550415
Sponsor: Indonesia University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Chemotherapy Effect Simvastatin Adverse Reaction

Start date: 2022-08-19
Primary completion: 2025-05-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.